Vaccine Alliance
- All
- News
- Videos
-
US Funding Cut Could Cause 'Over A Million Deaths': Vaccine Alliance CEO
The Gavi vaccine alliance's chief said on Thursday that any cut in US funding risks causing more than a million deaths, following a report that Washington is set to back out.
-
Trump Administration To Cut Vaccine Support To Developing Countries: Report
President Donald Trump's administration is set to cut funding to Gavi, the global health organization that provides vaccines across the developing world, a report said.
-
Covid Vaccine Scheme For The Poorest Pushes For Delivery Slowdown: Report
Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.
-
Global Vaccine Alliance, Bharat Biotech In Talks Over Covaxin Use: Report
The Gavi vaccine alliance is in talks with Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told news agency Reuters on Thursday.
-
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
-
Global Vaccine Alliance GAVI Hopes India Will Resume Exports In July Quarter
The GAVI vaccine alliance hopes the Serum Institute of India (SII) will resume exports of the AstraZeneca COVID-19 vaccine from this quarter, it told Reuters, which would be earlier than an "end of this year" forecast by the Indian company.
-
AstraZeneca, Pfizer Vaccines Effective Against Delta Covid Variants: Study
COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.
-
US Contributed $2 Billion To Global Alliance On Vaccines For Covax Facility
US has so far contributed $2 billion to GAVI for COVAX facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.
-
Covax Says Needs $2 Billion Additional Funding By June For Poor Countries
The Covax global vaccine-sharing programme said Thursday it needs $2.0 billion in additional funding by the beginning of June in order to boost coronavirus inoculation programmes in lower-income countries.
-
Nissan India Contributes Rs. 6.5 Crore Towards Fighting COVID-19
Nissan India announced that it contributed over Rs. 6.5 crore to local communities and the Tamil Nadu State Disaster Management Authority (SDMA) for COVID-19 relief.
-
India To Get Between 190 To 250 Million Subsidised Covid Vaccines: Gavi
Gavi, a global alliance on vaccines, on Friday said that India would receive between 190 and 250 million fully subsidised doses of COVID-19 vaccine and funds up to USD 30 million for urgent technical assistance and cold chain equipment.
-
The Pfizer/BioNTech Vaccine Bet That Paid Off
With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.
-
India Likely To Make Available Less Number Of Vaccines Globally: Gavi
India, which is experiencing a sudden rise in number of COVID-19 cases, is now likely to make available a smaller number of vaccines to the rest of the world, the head of the Global Alliance for Vaccines and Immunisation has said.
-
Pakistan To Soon Get 'Made-In-India' Vaccines Under Global Alliance
Pakistan will soon get 'made-in-India' coronavirus vaccinesunder the United Global Alliance for Vaccines and Immunization or GAVI, a public-private global health partnership to increase access to immunisation in poor countries.
-
India Seeks Funds From Quad To Match China's Vaccine Push: Report
India has urged the United States, Japan and Australia to invest in its vaccine production capacity, a government source told news agency Reuters, as the so-called Quad alliance tries to counter China's growing vaccine diplomacy.
-
US Funding Cut Could Cause 'Over A Million Deaths': Vaccine Alliance CEO
The Gavi vaccine alliance's chief said on Thursday that any cut in US funding risks causing more than a million deaths, following a report that Washington is set to back out.
-
Trump Administration To Cut Vaccine Support To Developing Countries: Report
President Donald Trump's administration is set to cut funding to Gavi, the global health organization that provides vaccines across the developing world, a report said.
-
Covid Vaccine Scheme For The Poorest Pushes For Delivery Slowdown: Report
Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.
-
Global Vaccine Alliance, Bharat Biotech In Talks Over Covaxin Use: Report
The Gavi vaccine alliance is in talks with Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told news agency Reuters on Thursday.
-
Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.
-
Global Vaccine Alliance GAVI Hopes India Will Resume Exports In July Quarter
The GAVI vaccine alliance hopes the Serum Institute of India (SII) will resume exports of the AstraZeneca COVID-19 vaccine from this quarter, it told Reuters, which would be earlier than an "end of this year" forecast by the Indian company.
-
AstraZeneca, Pfizer Vaccines Effective Against Delta Covid Variants: Study
COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study.
-
US Contributed $2 Billion To Global Alliance On Vaccines For Covax Facility
US has so far contributed $2 billion to GAVI for COVAX facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.
-
Covax Says Needs $2 Billion Additional Funding By June For Poor Countries
The Covax global vaccine-sharing programme said Thursday it needs $2.0 billion in additional funding by the beginning of June in order to boost coronavirus inoculation programmes in lower-income countries.
-
Nissan India Contributes Rs. 6.5 Crore Towards Fighting COVID-19
Nissan India announced that it contributed over Rs. 6.5 crore to local communities and the Tamil Nadu State Disaster Management Authority (SDMA) for COVID-19 relief.
-
India To Get Between 190 To 250 Million Subsidised Covid Vaccines: Gavi
Gavi, a global alliance on vaccines, on Friday said that India would receive between 190 and 250 million fully subsidised doses of COVID-19 vaccine and funds up to USD 30 million for urgent technical assistance and cold chain equipment.
-
The Pfizer/BioNTech Vaccine Bet That Paid Off
With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.
-
India Likely To Make Available Less Number Of Vaccines Globally: Gavi
India, which is experiencing a sudden rise in number of COVID-19 cases, is now likely to make available a smaller number of vaccines to the rest of the world, the head of the Global Alliance for Vaccines and Immunisation has said.
-
Pakistan To Soon Get 'Made-In-India' Vaccines Under Global Alliance
Pakistan will soon get 'made-in-India' coronavirus vaccinesunder the United Global Alliance for Vaccines and Immunization or GAVI, a public-private global health partnership to increase access to immunisation in poor countries.
-
India Seeks Funds From Quad To Match China's Vaccine Push: Report
India has urged the United States, Japan and Australia to invest in its vaccine production capacity, a government source told news agency Reuters, as the so-called Quad alliance tries to counter China's growing vaccine diplomacy.
